NCT07312175

Brief Summary

Research Title:A study on 3D printing-assisted platelet-rich plasma combined with autologous periosteum-bone grafting in the treatment of knee cartilage injury Objectives:(1) To evaluate the accuracy of cartilage damage repair by measuring the chimerism and surface curvature matching degree of 3D printing reconstruction. (2) 3D printing assisted platelerichplasma (PRP) combined with autologous periosteumBone grafting in patients with knee cartilage injury was evaluated for functional and imaging scores to evaluate the clinical effect and cartilage repair effect. Design Type:Prospective randomized controlled trial Research Objects:Unilateral knee cartilage injury area\>2CM2, international cartilagerepair society (ICRS) grade 3-4 patients Sample size: 60 cases (30 patients with 3D printing-assisted autologous periosteum-bone grafting, 3D printing-assisted PRP combined with autologous periosteum.) - 30 patients with bone grafting).Selection Criteria:(1) Age 18\~65 years old; (2) The body mass index (BMI) is 18\~30kg/m2 ; (3) Knee cartilage injury confirmed by imaging examination, knee cartilage injury 2\>cm2, ICRS grade 3-4; (4) There is no obvious abnormality in the lower limb force line; (5) No other drug injection or surgical treatment has been performed locally in the knee joint in the past 1 year. Observation indicators:(1) Clinical function(2) Imaging evaluation: Bilateral knee MRI examination was performed on the second day after surgery Statistical analysis methods:SPSS software was used for data analysis.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
45mo left

Started Aug 2025

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress17%
Aug 2025Dec 2029

Study Start

First participant enrolled

August 1, 2025

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 16, 2025

Completed
2 months until next milestone

First Posted

Study publicly available on registry

December 31, 2025

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2029

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2029

Last Updated

December 31, 2025

Status Verified

August 1, 2025

Enrollment Period

4.4 years

First QC Date

November 16, 2025

Last Update Submit

December 16, 2025

Conditions

Keywords

Autologous osteoperiosteal transplantationMassiveOsteochondral lesionsKnee

Outcome Measures

Primary Outcomes (1)

  • Clinical function

    (1) Clinical function: Knee joint obtained by outpatient follow-up, written questionnaires, or by telephone by trained medical professionals before surgery and 1, 3, 6, and 12 months after surgery Lysholm score, Tegner exercise ability score, and pain numeric score were used to assess the improvement of symptoms and function.Lysholm score:minimum:0,maximum:80,a higher score represents a better outcome;Tegner exercise ability score:minimum:0,maximum:80,a higher score represents a better outcome;pain numeric score:minimum:0,maximum:10,a higher score represents a worse outcome.)

    1 year

Secondary Outcomes (1)

  • Imaging evaluation

    1 year

Study Arms (2)

3D-Printed Scaffold-Assisted PRP Combined with Autologous Periosteal-Bone Grafting

EXPERIMENTAL

3D-Printed Scaffold-Assisted PRP Combined with Autologous Periosteal-Bone Grafting

Procedure: 3D-Printed Scaffold-Assisted PRP Combined with Autologous Periosteal-Bone GraftingProcedure: 3D Printing-Assisted Autologous Periosteal-Bone Grafting

3D Printing-Assisted Autologous Periosteal-Bone Grafting

OTHER

3D Printing-Assisted Autologous Periosteal-Bone Grafting

Procedure: 3D-Printed Scaffold-Assisted PRP Combined with Autologous Periosteal-Bone GraftingProcedure: 3D Printing-Assisted Autologous Periosteal-Bone Grafting

Interventions

3D-Printed Scaffold-Assisted PRP Combined with Autologous Periosteal-Bone Grafting

3D Printing-Assisted Autologous Periosteal-Bone Grafting3D-Printed Scaffold-Assisted PRP Combined with Autologous Periosteal-Bone Grafting

3D Printing-Assisted Autologous Periosteal-Bone Grafting

3D Printing-Assisted Autologous Periosteal-Bone Grafting3D-Printed Scaffold-Assisted PRP Combined with Autologous Periosteal-Bone Grafting

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-65 years;
  • Body Mass Index (BMI) 18-30 kg/m²;
  • Imaging-confirmed knee cartilage damage \>2 cm² with International Cartilage Repair Society (ICRS) grade 4;
  • No significant lower limb alignment abnormalities;
  • No prior local drug injections in the knee joint within the past year.

You may not qualify if:

  • Significant osteoporosis;
  • Individuals with immature bones;
  • Those with poor mechanical alignment;
  • Presence of meniscus injury, cruciate ligament or collateral ligament rupture, or incomplete healing following surgery for any of these conditions;
  • Severe knee joint effusion;
  • Use of corticosteroids or immunosuppressive agents;
  • Poor general health, alcoholism, or substance abuse;
  • Previous treatment with autologous blood products or stem cell preparations.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

330006

Nanchang, Jiangxi, China

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 16, 2025

First Posted

December 31, 2025

Study Start

August 1, 2025

Primary Completion (Estimated)

December 30, 2029

Study Completion (Estimated)

December 30, 2029

Last Updated

December 31, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Locations